Picture of Epigral logo

EPIGRAL Epigral Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
Basic MaterialsSpeculativeMid CapHigh Flyer

Annual cashflow statement for Epigral, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,6093,8345,2252,9075,401
Depreciation
Non-Cash Items291443614723450
Unusual Items
Other Non-Cash Items
Changes in Working Capital-343-2,299-667-889-2,771
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities2,2922,8386,2623,9764,406
Capital Expenditures-1,968-4,563-4,165-3,984-1,947
Purchase of Fixed Assets
Other Investing Cash Flow Items0.6616.7-208-26.7-669
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1,967-4,546-4,372-4,011-2,616
Financing Cash Flow Items-397-480-605-720-743
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-3191,952-1,998-76-1,635
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash5.83244-108-111155